Researchers at the Royal Melbourne Institute of Technology (RMIT) University in Melbourne, Australia, in collaboration with the Centre for Eye Research Australia (CERA), have developed a nanocarrier e
A major study of laser correction for myopia found that the procedure is as safe and effective in older teenagers as it is in adults, according to research presented at the European Society of Catarac
US researchers found the risk of progression to vision-threatening forms of diabetic retinopathy (DR) was more pronounced in eyes with moderate-to-severe non-proliferative DR (NPDR) at baseline.
Breaking new ground, EssilorLuxottica’s Stellest lens is the first-ever spectacle lens clinically proven to slow myopia progression in children to receive the US Food and Drug Administration’s (FDA’s) market authorisation.
New Zealand glaucoma specialists have welcomed Southern Cross’ decision to partially fund the latest iteration of the minimally invasive glaucoma surgery (MIGS) device, the iStent Infinite.
US researchers found patients with primary open-angle glaucoma (POAG) in lower-income groups were substantially less likely to achieve target intraocular pressure (IOP) reductions and more likely to d
A research consortium of more than 65 countries has launched Global RETFound, an initiative to develop the first globally representative artificial intelligence (AI) foundation model in medicine, usin
A photovoltaic retina implant has shown “clinically meaningful improvement” in vision for people with geographic atrophy from AMD, according to results published in the New England Journal of Medicine.
University of Auckland researchers are investigating how New Zealand patients feel about and respond to ‘self-referrals’ when doctors refer patients to healthcare providers in which they have a financial stake.
After more than a decade, NZ Optics publishers Lesley Springall and Nick Griffiths have sold their business to Auckland-based media-business duo James Butcher and Stephen Old.
US researchers using a mouse model of cerebrovascular disease found retinal vascular imaging and phenotype can function as a biomarker for Alzheimer's disease and related dementias (ADRD), particularl
LINK: https://www.nzoptics.co.nz/live-articles/visual-processing-speed-predicts-dementia/
